Latest Headlines

  1. Bora Pharmaceuticals Wins Canada's Safest New Employer Award 10/1/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of The Bruce Power Award for Canada’s Safest New Employer. The award, announced during the 2025 Canada’s Safest Employers ceremony in October, recognizes an exemplary safety record in less than 10 years of operation.

  2. ROSS Ribbon Blender Optimized For Efficient Powder Handling 9/30/2025

    Customizable ROSS Ribbon Blenders deliver reliable mixing of food, nutraceuticals, cosmetics, personal care products, in addition to chemicals, plastics, building materials and agricultural products.

  3. Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan 9/30/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced the addition of liquid-filled hard capsule (LFC) production capabilities at its Zhunan, Taiwan facility.

  4. Amgen Announces Significant Investment Into Puerto Rico Drug Manufacturing Site 9/26/2025

    The planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos and integrate innovative advanced technologies throughout the operations process.

  5. Wombat Capital Markets Advised Regis Technologies On Its Sale To Esteve 9/26/2025

    This strategic move allows ESTEVE CDMO a physical presence in the U.S., expanding its contract development and manufacturing solutions for innovative small-molecule APIs across the entire drug development lifecycle from pre-clinical to commercial manufacturing.

  6. Ritedose Scales Operations With $17M Laboratory Expansion 9/25/2025

    Ritedose is investing $17M to expand its cGMP labs, adding a 10,000 sq. ft. analytical chemistry facility and a 6,000 sq. ft. microbiology expansion to boost drug development and CDMO capabilities.

  7. Praxis Packaging Solutions Expands With Acquisition Of Advanced Concept Innovations, LLC 9/25/2025

    The strategic combination with ACI further enhances Praxis’ customer oPering by broadening Praxis’ geographic footprint into the Southeastern United States, expanding its capabilities and market segments.

  8. PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach 9/24/2025

    PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.

  9. $60M Series B Financing Propels Avenzo Therapeutics Forward 9/24/2025

    Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the closing of a $60 million Series B financing. This funding, which follows Avenzo’s $386 million Series A/A-1 financing announced in November 2024, brings the total capital raised to $446 million. The proceeds will be used to support the advancement of Avenzo’s pipeline of potential best-in-class oncology drug candidates.

  10. Eli Lilly's New Texas Facility To Boost Small Molecule Production 9/23/2025

    The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines.